Narrative Discourse Treatment for Traumatic Brain Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help veterans with traumatic brain injury (TBI) enhance their communication skills. It aims to improve storytelling in both content and organization, making everyday communication smoother. The trial includes two groups: one receives special biweekly sessions of narrative discourse treatment (a therapy for improving storytelling and communication), while the other continues their usual care without added treatment. Veterans with mild to moderate TBI who face communication issues affecting daily activities and can identify a close contact for support might be a good fit. Participants need stable housing, basic technology for telehealth, and must speak English as their primary language. As an unphased trial, this study offers veterans a unique opportunity to explore innovative communication therapies tailored to their needs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that regular marijuana use that interferes with daily functioning is not allowed.
What prior data suggests that this narrative discourse treatment is safe for Veterans with TBI?
Research has shown that treatments focusing on storytelling for people with traumatic brain injury (TBI) have been explored. In one study, speech-language experts collaborated to enhance thinking and communication skills. These treatments aim to help participants organize and share stories more effectively.
While specific safety details for storytelling treatments are not provided in the studies, the treatment—centered on communication and storytelling—is non-invasive and generally manageable for participants. Similar treatments have not reported any major negative effects.
In summary, based on past research and the nature of the treatment, storytelling therapy appears safe for people with TBI.12345Why are researchers excited about this trial?
Researchers are excited about narrative discourse treatment for traumatic brain injury (TBI) because it targets communication skills in a unique way. Unlike traditional therapies that often focus on cognitive rehabilitation through medication or standard speech therapy, this treatment involves biweekly sessions that specifically improve storytelling and conversation abilities. By concentrating on narrative skills, this approach aims to enhance social interaction and overall communication, which are often areas of struggle for those with TBI. This targeted method could provide a more personalized and effective intervention for improving the quality of life for TBI patients.
What evidence suggests that this narrative discourse treatment might be effective for traumatic brain injury?
Research has shown that narrative discourse treatment, which participants in this trial may receive, can help people with traumatic brain injury (TBI) improve their communication skills. This treatment focuses on storytelling and organizing stories, enhancing social interactions—an area often challenging for those with TBI. One study found that participants told clearer stories after this type of treatment. Another review highlighted the potential benefits but also noted the difficulty in measuring results. Although this research remains in the early stages, it suggests that narrative discourse treatment could help Veterans with TBI communicate better in their daily lives.12678
Who Is on the Research Team?
Karen Le, PhD
Principal Investigator
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Are You a Good Fit for This Trial?
This trial is for Veterans with mild to moderate TBI who experience communication difficulties. They must have a significant other to report on their discourse ability, be able to engage in telehealth sessions, and have stable housing. Excluded are those with penetrating head injuries, developmental disabilities, psychotic disorders, neurological illnesses other than TBI, aphasia or APD, or recent substance abuse.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive biweekly discourse treatment sessions to address narrative discourse impairments
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Narrative discourse treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor